These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 30851973)
1. Tacrolimus ointment in the management of atopic keratoconjunctivitis. Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J J Fr Ophtalmol; 2019 Apr; 42(4):e147-e151. PubMed ID: 30851973 [TBL] [Abstract][Full Text] [Related]
2. [Tacrolimus ointment in the management of atopic keratoconjunctivitis]. Benaim D; Tétart F; Bauvin O; Delcampe A; Joly P; Muraine M; Gueudry J J Fr Ophtalmol; 2019 May; 42(5):435-440. PubMed ID: 30935698 [TBL] [Abstract][Full Text] [Related]
3. Topical tacrolimus treatment of atopic eyelid disease. Rikkers SM; Holland GN; Drayton GE; Michel FK; Torres MF; Takahashi S Am J Ophthalmol; 2003 Mar; 135(3):297-302. PubMed ID: 12614745 [TBL] [Abstract][Full Text] [Related]
4. Topical tacrolimus ointment for treatment of refractory anterior segment inflammatory disorders. Joseph MA; Kaufman HE; Insler M Cornea; 2005 May; 24(4):417-20. PubMed ID: 15829797 [TBL] [Abstract][Full Text] [Related]
5. Dermatologic tacrolimus ointment on the eyelids for steroid-refractory vernal keratoconjunctivitis. Liu FY; Liu HY; Chu HS; Chen WL; Hu FR; Wang IJ Graefes Arch Clin Exp Ophthalmol; 2019 May; 257(5):967-974. PubMed ID: 30852635 [TBL] [Abstract][Full Text] [Related]
6. Tacrolimus ointment vs steroid ointment for eyelid dermatitis in patients with atopic keratoconjunctivitis. Nivenius E; van der Ploeg I; Jung K; Chryssanthou E; van Hage M; Montan PG Eye (Lond); 2007 Jul; 21(7):968-75. PubMed ID: 16680103 [TBL] [Abstract][Full Text] [Related]
7. Effect of 0.03% tacrolimus ointment on conjunctival cytology in patients with severe atopic blepharoconjunctivitis: a retrospective study. Virtanen HM; Reitamo S; Kari M; Kari O Acta Ophthalmol Scand; 2006 Oct; 84(5):693-5. PubMed ID: 16965503 [TBL] [Abstract][Full Text] [Related]
8. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment. Nahum Y; Mimouni M; Livny E; Bahar I; Hodak E; Leshem YA Br J Ophthalmol; 2020 Jun; 104(6):776-779. PubMed ID: 31554632 [TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up of tacrolimus ointment for treatment of atopic keratoconjunctivitis. Al-Amri AM Am J Ophthalmol; 2014 Feb; 157(2):280-6. PubMed ID: 24439439 [TBL] [Abstract][Full Text] [Related]
10. Topical Tacrolimus for Chronic Allergic Conjunctival Disease with and without Atopic Dermatitis. Shoji J; Ohashi Y; Fukushima A; Miyazaki D; Uchio E; Takamura E; Fujishima H; Namba K; Kumagai N; Ebihara N; Okamoto S Curr Eye Res; 2019 Jul; 44(7):796-805. PubMed ID: 30947551 [No Abstract] [Full Text] [Related]
11. Dramatic improvement of atopic keratoconjunctivitis after topical treatment with tacrolimus ointment restricted to the eyelids. Zribi H; Descamps V; Hoang-Xuan T; Crickx B; Doan S J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):489-90. PubMed ID: 18721214 [No Abstract] [Full Text] [Related]
12. Topical calcineurin inhibitors in the treatment of steroid-dependent atopic keratoconjunctivitis. Tzu JH; Utine CA; Stern ME; Akpek EK Cornea; 2012 Jun; 31(6):649-54. PubMed ID: 22378107 [TBL] [Abstract][Full Text] [Related]
13. Topical tacrolimus ointment for treatment of intractable atopic keratoconjunctivitis: a case report and review of the literature. García DP; Alperte JI; Cristóbal JA; Mateo Orobia AJ; Muro EM; Valyi Z; Del Rio BJ; Arnao MR Cornea; 2011 Apr; 30(4):462-5. PubMed ID: 20861732 [TBL] [Abstract][Full Text] [Related]
14. Topical tacrolimus for the treatment of severe allergic keratoconjunctivitis in children. Liendo VL; Vola ME; Barreiro TP; Wakamatsu TH; Gomes JÁP; Santos MSD Arq Bras Oftalmol; 2017; 80(4):211-214. PubMed ID: 28954018 [TBL] [Abstract][Full Text] [Related]
16. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option? Westland T; de Bruin-Weller MS; Van der Lelij A J Eur Acad Dermatol Venereol; 2013 Sep; 27(9):1187-9. PubMed ID: 23106347 [No Abstract] [Full Text] [Related]
17. Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus. Hirota A; Shoji J; Inada N; Shiraki Y; Yamagami S Cornea; 2022 Jan; 41(1):23-30. PubMed ID: 34870621 [TBL] [Abstract][Full Text] [Related]
18. The efficacy of 0.1% tacrolimus ophthalmic suspension in the treatment of severe atopic keratoconjunctivitis. Yazu H; Shimizu E; Aketa N; Dogru M; Okada N; Fukagawa K; Fujishima H Ann Allergy Asthma Immunol; 2019 Apr; 122(4):387-392.e1. PubMed ID: 30639466 [TBL] [Abstract][Full Text] [Related]